Two additional clean rooms, totaling 800 sqm, are completed at Nolato GW Dongguan to support the continuing growth of Medical Solutions business in south China. This project was completed in three months and now is ready to receive the planned transfer projects, business that is new to Nolato GW Dongguan. #Nolato #MedicalSolutions #CleanRooms #BusinessExpansion #Growth #NewFacilities
Nolato’s Post
More Relevant Posts
-
Discover the indications, advantages, and complications of the Type 1A protocol in alignment with the synergy concept with Paolo Casentini at the ITI World Symposium 2024. Be part of it in Singapore, May 2024 📆 Link in bio 🔗 #CasentiniAtITIWS24 #SynergyConcept #ITIWorldSymposium #ImplantologyInSingapore #ITIWS24 #DentalInnovation
To view or add a comment, sign in
-
📣 Upcoming #webinar: Discover our new interactive tool that highlights key regions for PtX export opportunities and calculates the delivery costs for various molecules. In collaboration with with Agora Industry and Oeko-Institut e.V., the PtX Hub unveils its Business Opportunity Analyser 2.0 – with enhanced cost calculations and with system optimisation. Join us on 🗓 Monday, 24 June 2024, 15:00 - 16:30 CEST 🌍 Online on Zoom ✍ Register for free at https://lnkd.in/eFy-z4Da The tool will allow users to calculate the delivery cost of #PtX molecules from an exporting country to an importing country, highlighting the competitive advantage of one country over another. This "pre-feasibility" level information will help to identify regions with promising business opportunities within the PtX value chain. Such information will also assist policy makers in understanding their country's specific PtX cost potentials, thereby supporting the development of targeted #policies to facilitate investment in PtX value chains. The tool will have a global scope, covering most potential exporting and importing countries, including a deep dive analysis with more regional detail for Argentina, Morocco and South Africa.
To view or add a comment, sign in
-
💠 International Power-to-X Hub is launching a new interactive tool that highlights key regions for #PtX export opportunities and calculates the delivery costs for various molecules. Join the webinar Online on Zoom on Monday, 24 June 2024, 15:00 - 16:30 CEST 🌍 ✍ Register for free at https://lnkd.in/eFy-z4Da 🤝 In collaboration with with Agora Industry and Oeko-Institut e.V., the PtX Hub unveils its Business Opportunity Analyser 2.0 – with enhanced cost calculations and with system optimisation. ⚙️ The tool will allow users to calculate the delivery cost of #PtX molecules from an exporting country to an importing country, highlighting the competitive advantage of one country over another. This "pre-feasibility" level information will help to identify regions with promising business opportunities within the PtX value chain. Such information will also assist policy makers in understanding their country's specific PtX cost potentials, thereby supporting the development of targeted #policies to facilitate investment in PtX value chains. The tool will have a global scope, covering most potential exporting and importing countries, including a deep dive analysis with more regional detail for Argentina, Morocco and South Africa.
📣 Upcoming #webinar: Discover our new interactive tool that highlights key regions for PtX export opportunities and calculates the delivery costs for various molecules. In collaboration with with Agora Industry and Oeko-Institut e.V., the PtX Hub unveils its Business Opportunity Analyser 2.0 – with enhanced cost calculations and with system optimisation. Join us on 🗓 Monday, 24 June 2024, 15:00 - 16:30 CEST 🌍 Online on Zoom ✍ Register for free at https://lnkd.in/eFy-z4Da The tool will allow users to calculate the delivery cost of #PtX molecules from an exporting country to an importing country, highlighting the competitive advantage of one country over another. This "pre-feasibility" level information will help to identify regions with promising business opportunities within the PtX value chain. Such information will also assist policy makers in understanding their country's specific PtX cost potentials, thereby supporting the development of targeted #policies to facilitate investment in PtX value chains. The tool will have a global scope, covering most potential exporting and importing countries, including a deep dive analysis with more regional detail for Argentina, Morocco and South Africa.
To view or add a comment, sign in
-
Did you know that Kikkoman Biochemifa Co. has been honored with not one, but TWO prestigious awards from the Japan Institute of Invention and Innovation? Their Lumitester Smart hygiene monitoring system, a GBAC STAR™ Registered Technology, has clinched both the Commissioner of Japan Patent Office Award and the Invention Implementation Achievement Award! Curious to learn more about GBAC's Registered Programs and Technology program, of which Kikkoman's Lumitester Smart system is a part? Ready to explore the cutting-edge innovations shaping the future of hygiene and safety? Click the link below to dive deeper and discover how you can be involved! Explore the GBAC STAR Registered Directory: https://lnkd.in/dmx2mZR8 Together, let's champion innovation and pave the way for a brighter, cleaner tomorrow! 💙 #GBACSTAR #HygieneInnovation #Kikkoman #SafetyFirst"
To view or add a comment, sign in
-
📰MTANZ article in the National Business Review (NBR) In case you missed it, there was a great article in the NBR yesterday written by a journalist that attended the MTANZ conference. Use the link below to read the article: https://lnkd.in/g8r72Hwk
To view or add a comment, sign in
-
General Medical Industrial Group Signed Strategic Cooperationwith Chinese Biggest government owned company SPEC. Now we own strong construction team and financial/money support If you have good relationship with your government? If you have channel to win project from your government? Let's work and win-win together #Partnership #StrategicCooperation #GeneralMedical #SPEC #Construction #FinancialSupport #GovernmentProjects
To view or add a comment, sign in
-
Quite some products in the Metal Working Fluids segment
“Innovation through Formulation” Read more on the Launch of Azeli’s L&MWF segment in Eastern Africa in the Lubezine Edition 48. https://lnkd.in/dRvx26hp
To view or add a comment, sign in
-
Senior Regulatory Affairs Manager | Medical Devices Regulatory Consultant | Co-Founder | Medical Writer
Let me know if you are interested to learn the classification of your IVD products in China
📢 China NMPA Implements Revised Classification Catalog for In Vitro Diagnostic Reagents 🧪 On May 21, 2024, the China NMPA announced the implementation of the revised Classification Catalog for In Vitro Diagnostic Reagents (IVD), in line with the Regulations for the Supervision and Administration of Medical Devices (State Council Order No. 739). This revision, aimed at enhancing the regulatory framework for IVD reagents, will take effect on January 1, 2025. 🔍 Key Highlights: **Separate Management Categories**: Products with the same analytes but different clinical purposes will be categorized separately based on their clinical applications. **Risk-Based Classification**: Reagents used for microbiological identification, drug sensitivity tests, cell culture media, and other specific reagents will be classified according to their risk and intended use. **Dynamic Updates**: The catalog will be updated dynamically based on risk analyses and evaluations of medical device production, operation, and usage. 📅 Transition Policies: - From now until June 30, 2024, entities can use either the original or revised catalog for filing IVD reagents. - From July 1, 2024, the revised catalog must be used for all new filings. - Existing products must be reviewed for compliance with the new catalog, with adjustments made by January 1, 2027. 🚀 BradyKnows Medical stands at the forefront of medical device innovation, providing elite expertise in the regulatory landscape of IVD reagents. Our comprehensive knowledge and meticulous approach ensure seamless compliance with evolving regulations, making us an invaluable partner in navigating the complexities of medical device classification and registration. For further inquiries regarding medical device registration, please contact us at 📧 info@bradyknowsmedical.com.
China NMPA Newsletter – February 2024
bradyknowsmedical.com
To view or add a comment, sign in
-
The April debrief analyzed recent advancements to the NHSA's lifecycle pricing framework and key policy directions for Huiminbao, focusing on their combined effects on the pricing and access pathways for innovative medicines in China. #China #InnovativeMedicine #PricingTrends #CommercialHealthInsurance
NRDL+ April 2024 Executive Debrief: Raising the Bar for Innovation
nrdlplus.com
To view or add a comment, sign in
-
I can’t miss my photo opportunity against our #transformational backdrop of 10th year anniversary of smoke-free in #philipmorrisjapan Philip Morris International. It was great catching up with PMJ colleagues to refresh every one’s knowledge on #PMIScience. Thanks to the Scientific Engagement Team for their meticulous preparation, we had interactive sessions Wataru Suzuki Hitomi Fukuhara Norihisa Sugimoto Mari Watanabe In our 10th year of heated tobacco product in Japan, we reflected on smoke-free progress since 2014: · The introduction of heated tobacco product most likely leads to faster cigarette sales decline in Japan (link 1. in comment) · We revisited problems related to burning tobacco – to smokers and others around them (link 2. in comment) · We discussed the potential of smoke-free products to reduce harm from cigarette smoking in Japan (link 3. in comment) Wow! My heart is full of pride, reflecting how much we have progressed in our smoke-free transformation journey #wearegamechangers #wearebettertogether #wecare #togetherX Shea Lih Goh Kenichi Kobayashi Cecilia Siu
To view or add a comment, sign in
11,096 followers
It’s a great team running this high performing operation, now expanded in two separate buildings and ready to take on your new projects. Come and visit us, it’s worth it.